Sectral and Myalgia aggravated - a phase IV clinical study of FDA data

Summary:

Myalgia aggravated is reported as a side effect among people who take Sectral (acebutolol hydrochloride), especially for people who are female, 60+ old, also take Crestor, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Myalgia aggravated when taking Sectral. It is created by eHealthMe based on reports of 3,508 people who have side effects when taking Sectral from the FDA, and is updated regularly.

What is Sectral?

Sectral has active ingredients of acebutolol hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 3,548 Sectral users. Check the latest studies of Sectral.

What is Myalgia aggravated?

Myalgia aggravated (muscle pain) is found to be associated with 1,881 drugs and 608 conditions by eHealthMe. Check the latest studies of Myalgia aggravated.

On Jul, 14, 2026

3,508 people reported to have side effects when taking Sectral.
Among them, 50 people (1.43%) have Myalgia aggravated.

Among these 50 people:

What is the gender of people who have Myalgia aggravated when taking Sectral? *

female: 51.02 %
male: 48.98 %

What is the age of people who have Myalgia aggravated when taking Sectral? *

What are other drugs people take besides Sectral? *

Crestor: 6 people, 12.00%
Aspirin: 5 people, 10.00%
Omeprazole: 5 people, 10.00%
Lasix: 5 people, 10.00%
Acetylsalicylate Lysine: 4 people, 8.00%
Effexor: 4 people, 8.00%
Zocor: 3 people, 6.00%
Allopurinol: 3 people, 6.00%
Plavix: 3 people, 6.00%
Cardizem Cd: 2 people, 4.00%

What are other side effects people have besides Myalgia aggravated? *

Weakness: 13 people, 26.00%
Fever: 12 people, 24.00%
Blood Creatine Phosphokinase Increased: 10 people, 20.00%
Joint Pain: 8 people, 16.00%
Chest Pain: 4 people, 8.00%
Pain In Limb: 4 people, 8.00%
Blood Creatine Phosphokinase Mb Increased: 4 people, 8.00%
Fall: 4 people, 8.00%
White Blood Cell Count Increased: 3 people, 6.00%
Myositis (inflammation of the muscles): 3 people, 6.00%

What are the existing conditions these people have? *

High Blood Cholesterol: 11 people, 22.00%
Type 2 Diabetes: 4 people, 8.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 4.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 4.00%
Depression: 2 people, 4.00%
Stress And Anxiety: 2 people, 4.00%
Intestinal Functional Disorder: 2 people, 4.00%
Ischaemic Cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease): 2 people, 4.00%
Lung Neoplasm Malignant (cancer tumour of lung): 2 people, 4.00%
Blood Uric Acid Increased: 2 people, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Sectral and have Myalgia aggravated?

- Check whether Myalgia aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sectral:

Sectral (3,548 reports)

Browse all side effects of Sectral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Myalgia aggravated:

Myalgia aggravated (1,881 drugs)

Browse all the conditions that are associated with Myalgia aggravated:

Myalgia aggravated (608 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acebutolol hydrochloride (the active ingredients of Sectral) and Sectral (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.